Stem Cells Europe, Amsterdam 1-3 September 2008
Select Biosciences are proud to announce their inaugural Stem Cells Europe conference which has been designed to review existing and new life science applications of stem cell research.
This year's event is to be held in
The agenda topics have been split into two sections – Research and Business & Ethics. The subjects that will be covered in the Research Track are: Advances in Tissue Engineering; Regenerative Medicine; Drug Discovery and Disease-Related Research; Therapeutic Advances Using Adult Somatic Stem Cells; Therapeutic Potential of Pluripotent Human Embryonic and Reprogrammed Somatic Stem Cells; Epigenetics. The Business & Ethics Track will be covering: Commercialization of Stem Cell Research; Start-Up Case Studies; Regulatory and IP Situation; Review of Bioethics Related to Stem Cells; Funding Sources for Stem Cell Research; Company Spotlight Presentations.
We have confirmed the following speakers from both Academia and Industry who have submitted some very interesting presentations: Stephen Minger, Director, Stem Cell Biology Laboratory, King's College; Bernard Siegel, Director, Genetics Policy Institute; Ian Wilmut, Director Centre for Regenerative Medicine, University of Edinburgh; Sheng Ding, Professor, Scripps Research Institute; Lorraine Young, Professor, Wolfson Centre for Stem Cells Tissue Engineering; Fergus McKenzie, Programme Manager, ITI Life Sciences; Dominique Bonnet, Senior Group Leader, Cancer Research; Magdi Yacoub, Professor, Imperial College London; Ingwer Koch, Director of Patent Law, European Patent Office; Julie Daniels, Head of Programme, University College London; Ursula Gehling, Head of Research, University Hospital ! Hamburg; Miriam Bibel, Project Head, Novartis Institutes for BioMedical Research; Alain Chapel, Principal Investigator, Institute of Nuclear Safety; Pier Lorenzo Puri, Assoiate Telethon Scientist, Dulbecco Telethon Institute; Karim Hayernia, Chair of Stem Cell Biology, NESCI; Ian Dimmick, Manager, North East England Stem Cell Institute; Stefan Przyborski, Director, Reinnervate Limited; Enal Razvi, Biotechnology Analyst, Select Biosciences; Thomas Skutella, Director, University of Tuebingen; Jolyon White, Technology Consultant, London Technology Network; Louise Leong, Science Director, Stem Cells for Safer Medicine; Nick Bassil, Patent Attorney, Kilburn & Strode; Phillipa Montgomerie, Associate, DLA Piper; Laure Brevignon, Research Associate, University ! of Cambridge; Cathy Prescott, Director, Biolatris
If you would like to present your research on a poster whilst attending the meeting you can still submit an abstract for consideration until 21st July 2008.
Alternatively if you are interested in Sponsorship or Exhibiting opportunities please contact the Exhibition Manager on paul.raggett@
Look forward to seeing you there!
Change settings via the Web (Yahoo! ID required)
Change settings via email: Switch delivery to Daily Digest | Switch format to Traditional
Visit Your Group | Yahoo! Groups Terms of Use | Unsubscribe
__,_._,___
